bilaterals.org logo
bilaterals.org logo

medicines


US, Australia drug dispute is holding up settlement of the Trans Pacific trade deal
A standoff between Australia and the United States on monopoly rules for pharmaceutical drugs has emerged as the ultimate impediment to clinching an historic trade deal sweeping across 12 Pacific Rim countries.
Latest TIFA talks ’productive’: US
The latest round of trade talks between Taiwan and the U.S. under the bilateral Trade and Investment Framework Agreement (TIFA) made much ground in a number of areas but both sides have yet to reach consensus on issues such as U.S. pork imports.
TIFA talks ignore interests of ordinary citizens: groups
The latest round of Trade and Investment Framework Agreement (TIFA) talks with the US ignores the interests of ordinary citizens, labor activists said yesterday.
TPP trade talks extended as negotiators struggle for a deal
The talks remained bogged down after two days of negotiations between ministers from the United States, Japan, Australia and nine other countries over a handful of sticky issues.
Nouvelle tentative pour conclure l’accord commercial trans-pacifique (TPP)
Les représentants de 12 pays riverains du Pacifique se réunissent à Atlanta pour tenter de parvenir à une entente sur un vaste accord commercial, connu sous son acronyme TPP.
Auto, dairy, drug issues arrest TPP talks
Major challenges in three areas remain in concluding the Trans-Pacific Partnership, according to officials involved in the discussions.
Cancer patient disrupts TPP negotiations
Arrested from hotel demanding to see the secret "death sentence clause"
Corporate power unbound: investor-state arbitration of IP monopolies on medicines - Eli Lilly v. Canada and the Trans-Pacific Partnership agreement
Despite the deep irony of free trade agreements being subverted to codify and extend anti-competitive monopoly rights the joining of enhanced intellectual property rights (IPRs) and strengthened investor rights is creating a wild-west opportunity for unbounded corporate power.
Intellectual property in the Trans-Pacific Partnership: increasing the barriers for the access to affordable medicines
Most free trade agreements signed by the United States, the European Union and the members of the European Free Trade Association (EFTA) contain chapters on intellectual property rights that expand the rights recognized to pharmaceutical companies.
At Obama-Modi meeting in New York, MSF urges India to protect affordable medicines for millions
Médecins Sans Frontières/Doctors Without Borders (MSF) warned that US pressure for India to change its intellectual property policies could result in millions of people around the world losing their lifeline of affordable medicines.
Top US lawmakers on trade urge action on India’s treatment of IPRs
The top members of US Congress and the Senate responsible for international trade issues urged the Obama administration to push for changes to India’s handling of intellectual property rights and technology
DHB backs off on TPP letter
The Whanganui District Health Board has acknowledged a letter sent to Dr Chris Cresswell expressing concerns over his views on the Trans-Pacific Partnership was "inappropriate", the Association of Salaried Medical Specialists says.
TPP protest arrest ’could cost doctor his job’
A doctor who jumped on a car carrying the deputy prime minister during a TPP protest and had to be forcibly removed could lose his job.
Update on the Regional Comprehensive Economic Partnership agreement – NGO briefing
While RCEP was initially framed as an agreement that would be more flexible for low and middle income countries, there is evidence that some governments from industrialised countries are seeking to pursue aspects which would be very damaging for developing countries.
Opposition mounts against regional trade pact threatening human rights
Less well known than the notorious Trans-Pacific Partnership, the Regional Comprehensive Economic Partnership (RCEP) is engendering growing opposition because of its similar oppressive provisions.
Alphachat podcast: Joe Stiglitz on minimum wage, monetary policy, TPP and more
Joseph Stiglitz, the Nobel Prize-winning economist, discusses TPP.
How Canada caved to US pressure at TPP talks in Hawaii
Negotiators dropped patent and copyright demands but failed to garner agreement.
EU, India working to resolve trade row over generic drugs
The EU and India are taking steps to end a trade row sparked by an EU ban of 700 Indian pharmaceutical products after New Delhi cancelled talks on a free trade accord earlier this month.
TPP in trouble: why we can win this fight!
Time is running out for a congressional vote on a completed TPP deal during President Obama’s term of office.
Why TPP threatens to undermine one of the fundamental principles of science
Data exclusivity is a kind of super-patent that is an incredibly powerful form of monopoly.